Verified July 2026 · Cited to primary sources
TB-500: Evidence Grade D — Animal studies only, unproven in humans.
The honest verdict
TB-500 is not FDA-approved and is under FDA review (July 23, 2026 PCAC). Human evidence is Grade D — the fragment sold to consumers has animal data only. The full-length Tβ4 human trials are a different molecule.
TB-500 at a glance
- Class
- Synthetic actin-binding peptide fragment (~7-aa active fragment of Tβ4)
- Mechanism
- Regulates actin and promotes cell migration, angiogenesis and wound healing — marketed for soft-tissue and tendon recovery.
- Also known as
- Thymosin Beta-4 fragment, TB4 fragment
- Research applications
- Soft-tissue and tendon/ligament recovery (preclinical)
- Wound healing (full-length Tβ4, a different molecule, reached human Phase 2)
- Forms
- subcutaneous injection
- Legal status
- Under FDA review
- WADA (anti-doping)
- Prohibited (S2 — Tβ4 and its derivatives explicitly named)
- Evidence grade
- Grade DAnimal studies only, unproven in humans
How we grade evidence
Every grade is assigned by a fixed A–F rubric — human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is TB-500?
The other half of the "wolverine stack" — soft-tissue recovery claims, but only animal data for the fragment actually sold.
Regulates actin and promotes cell migration, angiogenesis and wound healing — marketed for soft-tissue and tendon recovery.
How strong is the evidence for TB-500?
Grade D: animal/preclinical only for the TB-500 fragment, no human RCT (rule 5 fired). Note: full-length Thymosin β-4 reached human Phase 2 via RegeneRx — but that is a different molecule from the TB-500 fragment sold to consumers.
Primary sources (3)
Is TB-500 legal? (Status July 2026)
Regulatory limbo — July 2026 PCAC vote pending.
On the July 2026 PCAC docket
TB-500is one of the seven peptides the FDA's Pharmacy Compounding Advisory Committee reviews on July 23–24, 2026. Its legal compounding status could change after that vote. Track the FDA peptide vote →
What is TB-500 used for?
TB-500 is marketed for the goals below. See how it ranks against other peptides in each — by evidence, not hype.
What does TB-500 cost — and how do you access it legally?
Typical cost
UNKNOWN (usually bundled with BPC-157 courses, ~$350–$900)
No verified standalone clinic price. Commonly bundled with BPC-157 recovery courses; we mark the standalone number UNKNOWN rather than guess.
No legal supervised access route right now.
TB-500 has no compliant US route today while its compounding status is under FDA review. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole — we don't link them. If you pursue TB-500, do it with a licensed clinician, and re-check its legal status first.
Is TB-500safe? Side effects & risks
No human safety data for the fragment. Theoretical tumor-promotion via angiogenesis. Gray-market contamination. WADA-prohibited (S2).
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
TB-500 FAQ
Is TB-500 the same as Thymosin Beta-4?
Not exactly. TB-500 is a short synthetic fragment marketed as a Tβ4 stand-in. Full-length Thymosin β-4 reached human Phase 2 trials, but the fragment sold as TB-500 has only animal data — an important distinction the marketing blurs.
Is TB-500 FDA approved or legal?
No. TB-500 is not FDA-approved and has no legal supervised US route today. It was removed from 503A Category 2 in April 2026 and is on the July 23, 2026 PCAC docket.
Is the BPC-157 + TB-500 "wolverine stack" proven?
No. Both are Grade D — animal studies only. The stack is a community protocol, not something validated in human trials. We don't provide dosing for it.
Compare TB-500 with…
Head-to-head evidence-grade matchups people weigh against TB-500.
Keep reading
BPC-157
The most-hyped, least-human-proven "healing" peptide — extensive rodent data, zero published human trials.
Grade DKPV
An anti-inflammatory tripeptide studied for gut and skin inflammation — promising in cells and animals, untested in humans.
Grade BSermorelin
The "gentler," formerly-FDA-approved GH-axis peptide — the best-evidenced option you can still legally get through a compounding pharmacy.
The monthly peptide evidence brief.
What the research and the FDA actually say — one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.